Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare intraocular pressure lowering effectiveness of a new fixed combination drug.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Laboratorios Sophia S.A de C.V.
• Treatments: Brimonidine Tartrate; Dorzolamide; Timolol

Criteria

Inclusion Criteria:

• Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;

• Visual acuity of 20/40 to 20/80 or better (Snellen equivalent).

Exclusion Criteria:

• Clinically relevant ophthalmic or systemic conditions may be excluded.